Analysis

Cingulate Inc. (CING) Stock Analysis

Cingulate Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to CING.

websiteCING/analysis/CING

Cingulate Inc.

Cingulate Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to CING.

Stock profile

Ticker

CING

Asset type

Stock

Market cap

$67.2M

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Cingulate Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • CING primary listing

Latest Cingulate Inc. news

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

Exclusivity Extended into December 2042KANSAS CITY, Kan., June 16, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary ...

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26

Cingulate Receives Complete Response Letter from FDA for CTx-1301

Cingulate Receives Complete Response Letter from FDA for CTx-1301

Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD...

Cash Position Grows to $25.9 Million KANSAS CITY, Kan., May 14, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing

Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

U.S. Patent Notice of Allowance for CTx-1301 Received; Additional European Patents Granted Recent $12M Private Placement Closed At-the-Market Pricing KANSAS

Research sections

Valuation

Review valuation context for Cingulate Inc..

Future growth

Review future growth context for Cingulate Inc..

Past performance

Review past performance context for Cingulate Inc..

Financial health

Review financial health context for Cingulate Inc..

Dividend

Review dividend context for Cingulate Inc..

Management

Review management context for Cingulate Inc..

Ownership

Review ownership context for Cingulate Inc..

Other information

Review other information context for Cingulate Inc..

Community

Review community context for Cingulate Inc..